Senti Bio
Cell and Gene Therapy
0 open roles Cell and Gene Therapy South San Francisco, United States 69 employees $158M raised Est. 2016
New Enterprise Associates
Celadon Partners
Leaps by Bayer
Nantahala Capital
The Red Hook Fund LP
Matrix Partners China
About Senti Bio
- Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for patients living with incurable diseases.
- They have built a synthetic biology platform that enables them to program next-generation cell and gene therapies.
Senti Bio is listed on Rocketlist with 0 active roles. The company is categorized as Cell and Gene Therapy in BioTech. Senti Bio is at Public stage, with a B2B business model, headquartered in South San Francisco, United States. Senti Bio was founded in 2016 and has 69 employees. Senti Bio has raised $158M. Active roles are refreshed daily from public hiring sources.